Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Ipsen S.A.
  6. News
  7. Summary
    IPN   FR0010259150

IPSEN S.A.

(IPN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about IPSEN S.A.
06/18IPSEN  : A year-long partnership with the ISPC
PU
06/17IPSEN  : launches Perspectives Matter around World Kidney Cance...
PU
06/14ISPRM 2021 : New Ipsen analysis highlights potential treatment gap in adults liv..
AQ
06/11IPSEN  : Finds Potential Treatment Gap Among Spasticity Patients in US
MT
06/11IPSEN  : ISPMR 2021 – 11 June 2021.pdf
PU
06/07IPSEN  : Exelixis Say Phase 3 Trial of Cabozantinib Drug in Differentiated Thyro..
MT
06/07IPSEN  : Exelixis COSMIC-311 ASCO – 7 June 2021.pdf
PU
06/05IPSEN  : World Environment Day 2021
PU
05/31IPSEN  : US FDA Accepts Ipsen's Approval Request For Ultra-Rare Genetic Disorder..
MT
05/31IPSEN : Ex-dividend day for final dividend
FA
05/28IPSEN  : Palovarotene FDA acceptance – 28 May 2021.pdf
PU
05/28IPSEN  : Compensation policy for corporate officers, result of vote SM – 2..
PU
05/28IPSEN  : Information relating to compensation elements of ALC – 28 mai 202..
PU
05/28IPSEN  : Information relating to compensation elements of DL – 28 mai 2021..
PU
05/28IPSEN  : Our 2020 Integrated Annual Report now available for download
PU
More most relevant news
All news about IPSEN S.A.
06/18IPSEN  : A year-long partnership with the ISPC
PU
06/17IPSEN  : launches Perspectives Matter around World Kidney Cance...
PU
06/14ISPRM 2021 : New Ipsen analysis highlights potential treatment gap in adults liv..
AQ
06/11IPSEN  : Finds Potential Treatment Gap Among Spasticity Patients in US
MT
06/11IPSEN  : ISPMR 2021 – 11 June 2021.pdf
PU
06/07IPSEN  : Exelixis Say Phase 3 Trial of Cabozantinib Drug in Differentiated Thyro..
MT
06/07IPSEN  : Exelixis COSMIC-311 ASCO – 7 June 2021.pdf
PU
06/05IPSEN  : World Environment Day 2021
PU
05/31TODAY'S ANALYST RECOMMENDATIONS : Advanced Micro Devices, AstraZeneca, Bodycote,..
05/31IPSEN  : US FDA Accepts Ipsen's Approval Request For Ultra-Rare Genetic Disorder..
MT
More news
News in other languages on IPSEN S.A.
06/18IPSEN  : s'engage avec Gaëlle Edon dans ses défis sportifs !
06/18IPSEN S A  : Rediffusion AG – VF 2021.pdf
06/17IPSEN  : lance la campagne Perspectives Matter à l'occasion de ...
06/11Les valeurs à suivre aujourd'hui à la Bourse de Paris Vendredi 11 juin 2021
06/11IPSEN  : ISPMR 2021 – 11 Juin 2021.pdf
06/11IPSEN  : A suivre aujourd'hui
06/11IPSEN  : potentielles disparités dans le traitement de la spasticité chez l’adul..
06/07VALBIOTIS nomme un Directeur des Opérations Marketing et Commerciales
06/07IPSEN  : résultats détaillés présentés dans le DTC
06/07IPSEN  : Exelixis COSMIC-311 ASCO – 7 Juin 2021.pdf
More news
Analyst Recommendations on IPSEN S.A.
05/31TODAY'S ANALYST RECOMMENDATIONS : Advanced Micro Devices, AstraZeneca, Bodycote,..
2018European shares build on recovery, Airbus shines
RE
More recommendations
Press releases
06/18IPSEN  : A year-long partnership with the ISPC
PU
06/17IPSEN  : launches Perspectives Matter around World Kidney Cance...
PU
06/14ISPRM 2021 : New Ipsen analysis highlights potential treatment gap in adults liv..
AQ
06/11IPSEN  : ISPMR 2021 – 11 June 2021.pdf
PU
06/07IPSEN  : Exelixis COSMIC-311 ASCO – 7 June 2021.pdf
PU
More press releases
Upcoming event on IPSEN S.A.